Skip to main content

Search

Duke University and Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership
Duke Clinical Research Institute to Begin Nationwide Outcomes Study of Atrial Fibrillation Treatment
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
One-Third of Maximum Radiation Dose Obtained in Single Heart Attack Hospitalization
New Test May Predict Heart Disease Events and the Effect of Weight Loss on Insulin Resistance
New Heart Pump Extends Life of Heart Failure Patients
Duke Researchers Find Rapid Maturation of Neurons at Birth
Duke Heart Center Receives American College of Cardiology Foundation Performance Achievement Award
CDC Confirms Four New Cases of Oseltamivir (Tamiflu)-Resistant H1N1
DukeHealth.org Recognized by Peers as Leader in Patient Safety Communication
First Live Targeting of Tumors with RNA-Based Technology
Duke Medicine to Train Health Care Professionals in Health Informatics
Discovery Makes Brain Tumor Cells More Responsive to Radiation
Tests Show No Further Cases of Oseltamivir-Resistant H1N1 at Duke University Hospital
Why King Kong Failed to Impress
Most Oncologists Feel New Genetic Test for Tamoxifen Sensitivity Not Ready for the Clinic
Targeted Therapy Prolongs Life in Patients with HER2-Positive Breast Cancer
Duke University School of Medicine Names New Chair of Medicine
Duke University Health System Offering Community-Wide H1N1 Vaccination
NIA Awards $16 Million to Study Unexplained Anemia in Older Adults